Indaptus Therapeutics Statistics
Total Valuation
INDP has a market cap or net worth of $11.30 million. The enterprise value is $4.03 million.
Important Dates
The next estimated earnings date is Wednesday, March 12, 2025, before market open.
Earnings Date | Mar 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
INDP has 14.12 million shares outstanding. The number of shares has increased by 4.25% in one year.
Current Share Class | 14.12M |
Shares Outstanding | 14.12M |
Shares Change (YoY) | +4.25% |
Shares Change (QoQ) | +11.31% |
Owned by Insiders (%) | 35.34% |
Owned by Institutions (%) | 4.52% |
Float | 7.72M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.36 |
P/TBV Ratio | 1.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.42, with a Debt / Equity ratio of 0.02.
Current Ratio | 3.42 |
Quick Ratio | 3.31 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -139.60% and return on invested capital (ROIC) is -88.80%.
Return on Equity (ROE) | -139.60% |
Return on Assets (ROA) | -73.82% |
Return on Invested Capital (ROIC) | -88.80% |
Return on Capital Employed (ROCE) | -255.92% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.13M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.94% in the last 52 weeks. The beta is 1.11, so INDP's price volatility has been higher than the market average.
Beta (5Y) | 1.11 |
52-Week Price Change | -52.94% |
50-Day Moving Average | 0.89 |
200-Day Moving Average | 1.52 |
Relative Strength Index (RSI) | 44.64 |
Average Volume (20 Days) | 28,484 |
Short Selling Information
The latest short interest is 38,682, so 0.27% of the outstanding shares have been sold short.
Short Interest | 38,682 |
Short Previous Month | 66,422 |
Short % of Shares Out | 0.27% |
Short % of Float | 0.50% |
Short Ratio (days to cover) | 1.93 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -15.37M |
Pretax Income | -15.75M |
Net Income | -14.89M |
EBITDA | -15.37M |
EBIT | -15.37M |
Earnings Per Share (EPS) | -$1.71 |
Full Income Statement Balance Sheet
The company has $7.38 million in cash and $107,989 in debt, giving a net cash position of $7.27 million or $0.51 per share.
Cash & Cash Equivalents | 7.38M |
Total Debt | 107,989 |
Net Cash | 7.27M |
Net Cash Per Share | $0.51 |
Equity (Book Value) | 6.00M |
Book Value Per Share | 0.59 |
Working Capital | 5.40M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -11.53M |
Capital Expenditures | n/a |
Free Cash Flow | -11.53M |
FCF Per Share | -$0.82 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |